Cargando…
Benefits of tolvaptan on early dyspnea relief in patients with acute heart failure: A meta‐analysis
Considering the prevalence of dyspnea in acute heart failure (AHF), its reduction is important to both patients and caregivers. This meta‐analysis was performed to determine the efficacy and safety of tolvaptan on early dyspnea relief in patients with AHF. A systematic search was made of PubMed, Emb...
Autores principales: | Shang, Wenli, Zhang, Yingying, Han, Dong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9574714/ https://www.ncbi.nlm.nih.gov/pubmed/35916355 http://dx.doi.org/10.1002/clc.23889 |
Ejemplares similares
-
Comment on: Benefits of tolvaptan on early dyspnea relief in patients with acute heart failure: A meta‐analysis
por: Yin, Cong, et al.
Publicado: (2023) -
Clevidipine-induced Dyspnea Relief in Acute Heart Failure Patients
por: Stoicea, Nicoleta, et al.
Publicado: (2016) -
Tolvaptan in reversing worsening acute heart failure: A systematic review and meta-analysis
por: Wang, Lili, et al.
Publicado: (2019) -
Tolvaptan, hyponatremia, and heart failure
por: Zmily, Hammam D, et al.
Publicado: (2011) -
Effects of Tolvaptan in patients with acute heart failure: a systematic review and meta-analysis
por: Wang, Chunbin, et al.
Publicado: (2017)